Skip to main content

Gene Biotherapeutics Inc. (CRXM)

OTCMKTS: CRXM · Delayed Price · USD
0.00 0.00 (0.00%)
Dec 9, 2021 5:58 AM EST - Market closed
Market Capn/a
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out64.93M
EPS (ttm)0.07
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Beta1.09
Analystsn/a
Price Targetn/a
Earnings Daten/a

About CRXM

Gene Biotherapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of angiogenic gene therapy biotherapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product candidate is Generx, an angiogenic gene therapy product candidate in Phase 3 clinical trials for the potential treatment of patients with myocardial ischemia and refractory angina due to advanced coronary artery disease. It is also developing Generx for ischemia-related cardiovascular and cerebr...

IndustryBiotechnology
Founded2003
CEOChristopher Reinhard
Employees4
Stock ExchangeOTCMKTS
Ticker SymbolCRXM
Full Company Profile

News

There is no news available yet.